Delivery Order SPE2DB25D3201-SPE2DB25FNTVK

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,490.15, is for the delivery of QSYMIA 3.75 MG-23 MG capsules. It is a firm fixed-price delivery order contract with a completion date of June 4, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with an ultimate completion date of June 10, 2025 and a ceiling value of $1,032.01. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.65, is for the delivery of 4564986447 QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of June 25, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corp is the prime contractor and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific pharmaceutical product, QSYMIA 3.75 MG-23 MG CAPSULE 30S, with a ceiling value of $1,110.96 and a completion date of June 4, 2025. The contract type is Firm Fixed Price. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of QSYMIA 3.75 MG-23 MG capsules, with a ceiling value of $4,145.22 and a completion date of September 11, 2024. This contract is not set-aside and is a firm fixed-price delivery order. Amerisourcebergen is a prominent supplier of pharmaceutical products and medical supplies to various federal...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,385.86 Firm Fixed Price delivery order is for the supply of QSYMIA 3.75 MG-23 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,628.36, is a Firm Fixed Price contract for the delivery of 4564604902 - QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract does not have a set-aside designation, indicating open competition. While AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4568448460 QSYMIA 3.75 MG-23 MG CAPSULE 30S, with a ceiling value of $1,976.80. The contract type is a delivery order under a firm fixed price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,350.68, is for the delivery of Qsymia 3.75 mg-23 mg capsules in quantities of 30. The contract has a firm fixed price pricing type and an ultimate completion date of May 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.40, is for the delivery of the prescription medication Qsymia 3.75 mg-23 mg capsules. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTVK
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568520731 - QSYMIA 3.75 MG-23 MG CAPSULE 30S, a prescription medication. The total ceiling value of the contract is $1,587.98, with a firm fixed price pricing type. The contract has an ultimate completion date of June 12, 2025. This appears to be a non-set-aside contract, meaning it was open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of that larger IDC contract, enabling the company to supply a range of pharmaceutical products and medical supplies to support military healthcare programs.

Generated 9/10/25, 10:07 AM